Andy Burnham has set out a £48 million partnership to help more people take part in dementia research and accelerate the testing of potential treatments.
The Government announced the package on 8 October ahead of the Innovation Nation Summit. It includes £33 million through the Dame Barbara Windsor Dementia Goals programme, alongside industry funding.
Bristol Myers Squibb, GSK and Gates Ventures are contributing to the partnership, which will support the not-for-profit BARBARA Alliance.
Its programme is intended to connect health data, research and clinical-trial capabilities across the UK, helping researchers identify suitable participants.
Burnham said he wanted dementia research to become a national priority. The announcement also identifies dementia as an early priority for the planned Health Data Research Service.
The funding supports research into possible treatments. The announcement does not establish that a cure or a new treatment has been delivered.
